Cargando…
The Hippo signaling pathway in gastric cancer: Targeting Hippo for GC treatment
Gastric cancer (GC) is an aggressive malignant disease which still lacks effective early diagnosis markers and targeted therapies, representing the fourth-leading cause of cancer-associated death worldwide. The Hippo signaling pathway plays crucial roles in organ size control and tissue homeostasis...
Autores principales: | Cao, Zhifa, An, Liwei, Han, Yi, Jiao, Shi, Zhou, Zhaocai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326414/ https://www.ncbi.nlm.nih.gov/pubmed/36924251 http://dx.doi.org/10.3724/abbs.2023038 |
Ejemplares similares
-
Combinatorial targeting of Hippo-STRIPAK and PARP elicits synthetic lethality in gastrointestinal cancers
por: An, Liwei, et al.
Publicado: (2022) -
Hippo Pathway in Cancer, towards the Realization of Hippo-Targeted Therapy
por: Hata, Yutaka
Publicado: (2018) -
VGLL4 targets a TCF4–TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer
por: Jiao, Shi, et al.
Publicado: (2017) -
Architecture, substructures, and dynamic assembly of STRIPAK complexes in Hippo signaling
por: Tang, Yang, et al.
Publicado: (2019) -
Antitumor Effects of Paeoniflorin on Hippo Signaling Pathway in Gastric Cancer Cells
por: Niu, Kai, et al.
Publicado: (2021)